CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets
- 3 March 2005
- journal article
- Published by Springer Nature in Leukemia
- Vol. 19 (5), 835-840
- https://doi.org/10.1038/sj.leu.2403704
Abstract
The activation of natural killer (NK) cells leads to degranulation and secretion of cytotoxic granula. During this process, the lytic granule membrane protein CD107a becomes detectable at the cell surface. Based on this phenomenon, we have analyzed by a novel flow cytometry-based assay, the number and phenotype of NK cells responding to tumor targets. Using human leukemia and lymphoma cell lines, we observed a close correlation between CD107a surface expression and target cell lysis, indicating that NK cell cytotoxicity can be assessed by this method. The number of degranulating NK cells was closely related to the ratio of effector and target cells and showed a maximum at a ratio of 1:1. Moreover, we were able to show that the population of CD56dim/CD16neg NK cells is primarily responsible for the cytotoxic activity against tumor targets whereas neither CD56dim/CD16pos nor CD56bright NK cells degranulated in response to the cell lines. Our results indicate that the CD107a assay represents a promising new method for the quantification and characterization of cells exhibiting natural cytotoxicity.Keywords
This publication has 29 references indexed in Scilit:
- Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T CellsThe Journal of Experimental Medicine, 2004
- Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantationEuropean Journal of Immunology, 2004
- Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsNature Medicine, 2003
- CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunityBlood, 2003
- Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519)Leukemia, 1997
- Lysosome-Associated Membrane Proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) Are Activation-Dependent Cell Surface Glycoproteins in Human Peripheral Blood Mononuclear Cells Which Mediate Cell Adhesion to Vascular EndotheliumCellular Immunology, 1996
- Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.The Journal of Experimental Medicine, 1991
- Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; Evidence of leukemic origin by immunoglobulin gene rearrangementLeukemia Research, 1990
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982
- Letter to the editorInternational Journal of Cancer, 1977